Nataliya Virstyuk
The Ivano-Frankivsk National Medical University, Ukraine
Title: NAFLD Biomarker development and progression in psoriasis patients with metabolic syndrome
Biography
Biography: Nataliya Virstyuk
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome (MS) and comprises a disease spectrum ranging from steatosis through nonalcoholic steatohepatitis (NASH) to fibrosis and liver cirrhosis. Psoriasis is a chronic inflammatory skin disease, which commonly associated with MS or its components. The aim of this study was to investigate the NAFLD biomarker development and progression in psoriasis patients with MS